MedPath
NMPA Approval

Mizoribine Tablets

国药准字HJ20140244

September 24, 2024

H20140244

Drug Information

咪唑立宾片

布累迪宁

片剂

50mg

化学药品

September 24, 2024

September 23, 2029

Company Information

Applicant Company

1-1-2 Yurakucho, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

asahi kasei pharma corporation,nagoya pharmaceuticals plant

61 Ikeda,Fukuta-cho,Miyoshi-shi,Aichi,Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

咪唑立宾片 - NMPA 批准文号 | MedPath